InternationalUSRemember you can easily switch between MIP US and MIP International at any time

An overview and update on biosimilars

By Stephen Paul Mahinka and Kathleen M. Sanzo of Morgan, Lewis & Bockius.

The Patient Protection and Affordable Care Act of 2010 ("PPACA" or "the Act") will significantly affect biopharma growth and investment. A major element of this healthcare reform law is the Biologics Price Competition and Innovation Act ("BPCIA").

The BPCIA provides...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null



July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable

Most read articles